Ototoxic hearing loss
ICD-10 H91.0 is a billable code used to indicate a diagnosis of ototoxic hearing loss.
Ototoxic hearing loss refers to hearing impairment resulting from exposure to ototoxic agents, which can include certain medications, chemicals, or environmental factors that damage the inner ear structures. This condition can manifest as a gradual or sudden loss of hearing, often accompanied by tinnitus (ringing in the ears) or balance issues. The severity and type of hearing loss can vary based on the duration and level of exposure to the ototoxic substance. Common ototoxic medications include aminoglycoside antibiotics, cisplatin, and loop diuretics. Clinically, patients may present with complaints of difficulty hearing, especially in noisy environments, and may require audiometric testing to assess the degree of hearing loss. Diagnosis is typically confirmed through a combination of patient history, audiological evaluations, and sometimes imaging studies to rule out other causes of hearing impairment. Management may involve discontinuation of the ototoxic agent, hearing aids, or cochlear implants in severe cases. Early recognition and intervention are crucial to mitigate the impact of ototoxicity on hearing.
Detailed patient history, audiometric test results, and treatment plans must be documented.
Patients presenting with sudden hearing loss after starting a new medication or those with a history of chemotherapy.
Ensure that all ototoxic medications are listed and that the patient's response to treatment is documented.
Comprehensive audiological evaluations and patient history regarding ototoxic exposure.
Routine assessments of patients on long-term ototoxic medications.
Document the specific tests performed and their results to support the diagnosis.
Used for patients with suspected ototoxic hearing loss to assess hearing function.
Audiometric test results must be documented, including thresholds and speech recognition scores.
Otolaryngologists and audiologists should ensure that all relevant findings are included in the report.
Common causes include exposure to certain medications such as aminoglycosides, chemotherapy agents like cisplatin, and environmental toxins. It is important to review the patient's medication history and potential environmental exposures.
